BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22892605)

  • 1. Prospective audit of post-chemotherapy febrile neutropenia in patients with solid cancer and lymphoma in two Singaporean cancer centres.
    Wong M; Jin J; Tan MH; Lee YM; Lee TE; Ding Y; Yong HC; Lim SE; Chai LY; Chau NM; Hsu LY
    Ann Acad Med Singap; 2012 Jul; 41(7):287-93. PubMed ID: 22892605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology and clinical course of febrile neutropenia in children with cancer.
    Hakim H; Flynn PM; Knapp KM; Srivastava DK; Gaur AH
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):623-9. PubMed ID: 19644403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, management and economic impact of febrile neutropenia in oncology patients receiving routine care at a regional UK cancer centre.
    Schelenz S; Giles D; Abdallah S
    Ann Oncol; 2012 Jul; 23(7):1889-93. PubMed ID: 22048152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
    Innes H; Lim SL; Hall A; Chan SY; Bhalla N; Marshall E
    Support Care Cancer; 2008 May; 16(5):485-91. PubMed ID: 17899215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study.
    Agyeman P; Kontny U; Nadal D; Leibundgut K; Niggli F; Simon A; Kronenberg A; Frei R; Escobar H; Kühne T; Beck-Popovic M; Bodmer N; Ammann RA
    Pediatr Infect Dis J; 2014 Sep; 33(9):e219-25. PubMed ID: 24618935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology of febrile neutropenia in adult patients with hematologic neoplasms in a period of 26 months in Hospital Pablo Tobón Uribe, Colombia].
    Madrid C; Díaz L; Combariza J; Gálvez K; Olaya V; Ramírez I; Donado J
    Rev Chilena Infectol; 2013 Apr; 30(2):195-201. PubMed ID: 23677158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs associated with febrile neutropenia in solid tumor and lymphoma patients - an observational study in Singapore.
    Wang XJ; Wong M; Hsu LY; Chan A
    BMC Health Serv Res; 2014 Sep; 14():434. PubMed ID: 25252614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective audit of febrile neutropenia management at a tertiary university hospital in Singapore.
    Jin J; Lee YM; Ding Y; Koh LP; Lim SE; Lim R; Tambyah PA; Hsu LY
    Ann Acad Med Singap; 2010 Jun; 39(6):453-9. PubMed ID: 20625621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
    Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
    Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients.
    Schlapbach LJ; Aebi C; Otth M; Leibundgut K; Hirt A; Ammann RA
    Pediatr Infect Dis J; 2007 Nov; 26(11):989-94. PubMed ID: 17984804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality, length of stay, and cost associated with hospitalized adult cancer patients with febrile neutropenia.
    Chindaprasirt J; Wanitpongpun C; Limpawattana P; Thepsuthammarat K; Sripakdee W; Sookprasert A; Wirasorn K
    Asian Pac J Cancer Prev; 2013; 14(2):1115-9. PubMed ID: 23621197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of febrile neutropenia in patients receiving chemotherapy for solid tumors: a retrospective study of twenty cases from the radiotherapy centre, Accra, Ghana.
    Vanderpuye V; Yarney J; Beecham K
    West Afr J Med; 2010; 29(5):303-8. PubMed ID: 21089015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs associated with febrile neutropenia in the US.
    Michels SL; Barron RL; Reynolds MW; Smoyer Tomic K; Yu J; Lyman GH
    Pharmacoeconomics; 2012 Sep; 30(9):809-23. PubMed ID: 22804805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical practice patterns of managing low-risk adult febrile neutropenia during cancer chemotherapy in the USA.
    Freifeld A; Sankaranarayanan J; Ullrich F; Sun J
    Support Care Cancer; 2008 Feb; 16(2):181-91. PubMed ID: 17943327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital.
    Poon LM; Jin J; Chee YL; Ding Y; Lee YM; Chng WJ; Chai LY; Tan LK; Hsu LY
    Singapore Med J; 2012 Nov; 53(11):720-5. PubMed ID: 23192498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia.
    Choi CW; Sung HJ; Park KH; Yoon SY; Kim SJ; Oh SC; Seo JH; Kim BS; Shin SW; Kim YH; Kim JS
    Am J Hematol; 2003 Aug; 73(4):263-6. PubMed ID: 12879430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An audit of febrile neutropenia cases from a rural cancer center in India.
    Patil VM; Chakarborty S; Kumar MS; Geetha M; Dev S; Samuel S; Ahmed G; Nayanar SK; Vineetha R; Nair CK
    Indian J Cancer; 2014; 51(4):487-90. PubMed ID: 26842173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Consensus: Rational approach towards the patient with cancer, fever and neutropenia].
    Santolaya ME; Rabagliati R; Bidart T; Payá E; Guzmán AM; Morales R; Braun S; Bronfman L; Ferrés M; Flores C; García P; Letelier LM; Puga B; Salgado C; Thompson L; Tordecilla J; Zubieta M; ;
    Rev Chilena Infectol; 2005; 22 Suppl 2():S79-113. PubMed ID: 16311689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-risk febrile neutropenia in a medical oncology unit.
    Leong DC; Kinlay S; Ackland S; Bonaventura A; Stewart JF
    Aust N Z J Med; 1997 Aug; 27(4):403-7. PubMed ID: 9448881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India.
    Rajendranath R; Balasubramaniyum VK; Vijayakumar V; Ganesan P; Tenali GS
    Indian J Cancer; 2014; 51(4):481-6. PubMed ID: 26842171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.